Discover
VRAX
Virax Biolabs Group Limited
2.82
18 x 2.71
1 x 2.88
bid
ask
+
0.04
1.44%
5 @ 04:00 PM
2.82 +0.00 (0.00%)
| Ytd | -67.40% | |
| 1y | -84.96% |
2.71
day range
2.86
2.50
52 week range
21.75
| Open | 2.82 | Prev Close | 2.78 | Low | 2.71 | High | 2.86 | Mkt Cap | 526.28K |
| Vol | 30.16K | Avg Vol | 2.20M | EPS | -61.75 | P/E | -0.05 | Forward P/E | -1.01 |
| Beta | 1.35 | Short Ratio | 0.11 | Inst. Own | 5.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.66 | 200-d Avg | 6.35 | 1yr Est | 20.00 |
| Income Statement | |||
| Weighted Average Shares | 397.59K | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.44M | ||
| Cash and Equivalents (USD) | 6.44M | ||
| Current Assets | 6.83M | ||
| Property, Plant & Equipment Net | 1.50M | ||
| Total Assets | 8.32M | ||
| Debt Current | 109.58K | ||
| Total Debt | 414.39K | ||
| Current Liabilities | 685.02K | ||
| Debt Non-Current | 304.81K | ||
| Total Liabilities | 989.83K | ||
| Accumulated Retained Earnings (Deficit) | -29.61M | ||
| Accumulated Other Comprehensive Income | -310.28K | ||
| Shareholders Equity | 7.58M | ||
| Shareholders Equity (USD) | 7.58M | ||
| Assets Non-Current | 1.50M | ||
| Total Debt (USD) | 414.39K | ||
| Liabilities Non-Current | 304.81K | ||
| Trade and Non-Trade Payables | 575.45K | ||
| Tax Assets | 27.11K | ||